COVID-19 Monoclonal Antibodies
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments

Released: April 21, 2022

Expiration: April 20, 2023

Gregory Huhn
Gregory Huhn, MD, MPHTM

Activity

Progress
1
Course Completed

The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk of complications from acquiring COVID-19 or treatment of high-risk patients who have a mild to moderate COVID-19 infection. Listen as Gregory Huhn, MD, MPHTM, discusses when and how to use monoclonal antibodies including:

  • Bebtelovimab
  • Cilgavimab/tixagevimab
  • Sotrovimab